Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 known ✓ | P03952 | 7/20 | 0.52 |
| ▸ | HDAC11 known ✓ | Q96DB2 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 12/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 12/20 | 0.52 |
| ▸ | PLAT | P00750 | 11/20 | 0.52 |
| ▸ | F2 | P00734 | 11/20 | 0.52 |
| ▸ | F10 | P00742 | 10/20 | 0.52 |
| ▸ | PRSS2 | P07478 | 9/20 | 0.52 |
| ▸ | PRSS3 | P35030 | 9/20 | 0.52 |
| ▸ | F7 | P08709 | 6/20 | 0.52 |
| ▸ | HPN | P05981 | 4/20 | 0.44 |
| ▸ | PLG | P00747 | 6/20 | 0.42 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6439094 | 1.00 | PLAU (0.52) | PLAUPRSS1PLATF2F10 | |
| SCHEMBL30478743 | 0.98 | PLAU (0.53) | PLAUPRSS1PLATF2F10 | |
| SCHEMBL1458860 | 0.98 | PLAU (0.53) | PLAUPRSS1PLATF2F10 | |
| Hydrochloric Acid SCHEMBL9057304 | 0.79 | F2 (0.49) | PLAUPRSS1PLATF2F10 | |
| SCHEMBL15271248 | 0.78 | F2 (0.50) | PLAUPRSS1PLATF2F10 | |
| SCHEMBL5073378 | 0.75 | KDM4E (0.49) | PLAUPRSS1PLATF2F10 | |
| Hydrochloric Acid SCHEMBL4551001 | 0.74 | F2 (0.37) | PLAUPRSS1PLATF2F10 | |
| SCHEMBL2874094 | 0.74 | F2 (0.59) | PLAUPRSS1PLATF2F10 | |
| SCHEMBL2864097 | 0.74 | PLAU (0.52) | PLAUPRSS1PLATF2F10 | |
| Hydrochloric Acid SCHEMBL6341904 | 0.72 | BLM (0.50) | PLAUPRSS1PLATF2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025127798-A1 | STRONTIUM-EMITTING 3D PRINTING SCAFFOLD FOR PROMOTING BONE CARTILAGE REGENERATION AND METHOD FOR MANUFACTURING SAME | 단국대학교 천안캠퍼스 산학협력단 | 2025-06-19 | — | — | WO | disclosed |
| EP-4346771-A1 | NANOTECHNOLOGICAL PLATFORM BASED ON POLYURETHANE/POLYUREA CHEMISTRY TO FURNISH WATER-OIL-WATER MULTI WALLED AND FUNCTIONALIZABLE NANOCAPSULES AND THEIR PREPARATION PROCESS | Ecopol Tech, S.L. (ES) | 2024-04-10 | — | — | EP | disclosed |
| EP-4335433-A1 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS AND PREPARATION METHOD THEREFOR | Icure BNP Co., Ltd. (KR) | 2024-03-13 | — | — | EP | disclosed |
| WO-2024038345-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2024-02-22 | — | — | WO | disclosed |
| US-20240041917-A1 | TREATMENT FOR METHAMPHETAMINE CARDIOVASCULAR DISEASE | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2024-02-08 | — | — | US | disclosed |
| US-11883426-B2 | Treatment for methamphetamine cardiovascular disease | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2024-01-30 | — | — | US | disclosed |
| WO-2024019246-A1 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS AND PREPARATION METHOD THEREFOR | 주식회사 아이큐어비앤피 | 2024-01-25 | — | — | WO | disclosed |
| EP-4304582-A1 | COMPOSITIONS AND METHODS FOR TREATING ADDICTIONS COMPRISING 5-MEO-DMT | Alvarius Pharmaceuticals Ltd. (IE) | 2024-01-17 | — | — | EP | disclosed |
| CN-117297993-A | Composition for inducing growth of skin cells whose growth is inhibited by aging comprising flavonoids derived from camellia japonica | 株式会社爱茉莉太平洋 | 2023-12-29 | — | — | CN | disclosed |
| US-20230392116-A1 | METHOD FOR DIFFERENTIATING CORNEAL ENDOTHELIAL CELL-LIKE CELLS FROM PLURIPOTENT STEM CELLS | STEMSIGHT OY (FI) | 2023-12-07 | — | — | US | disclosed |
| US-6417223-B1 | ANTIPROLIFERATION AGENTS OR APOTOPSIS | RESEARCH DEVELOPMENT FOUNDATION | 2002-07-09 | — | — | US | disclosed |
| US-6406843-B1 | MICROORGANISM FOR USE IN VACCINATION AGAINST VIRAL DISEASES | UNIVERSITY OF ARKANSAS | 2002-06-18 | — | — | US | disclosed |
| EP-1203227-A1 | SYSTEM AND METHOD FOR PRENATAL DIAGNOSTIC SCREENING | BIOSEPARATIONS, INC. (US) | 2002-05-08 | — | — | EP | disclosed |
| US-20020048806-A1 | POULTRY VIRUS ISOLATES AND METHOD | ARKANSAS, UNIVERSITY OF | 2002-04-25 | — | — | US | disclosed |
| WO-2002026815-A2 | IDENTIFICATION OF NEUROBLASTOMA TUMOR SUPPRESSOR GENES | VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE (BE) | 2002-04-04 | — | — | WO | disclosed |
| US-6322792-B1 | GAMMA-2 HERPES VIRUSES LIKE KAPOSI'S SARCOMA-ASSOCIATED HERPES VIRUS USEFUL IN MODULATING PERSISTENCE OF HETEROLOGOUS DNA; GENE THERAPY | Kieff, Elliott D. | 2001-11-27 | — | — | US | disclosed |
| US-20010029013-A1 | Bcl-G polypeptides, encoding nucleic acids and methods of use | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | 2001-10-11 | — | — | US | disclosed |
| WO-2000075647-A1 | SYSTEM AND METHOD FOR PRENATAL DIAGNOSTIC SCREENING | BIOSEPARATIONS, INC. (US) | 2000-12-14 | — | — | WO | disclosed |
| EP-1019508-A1 | TNF-RELATED DEATH LIGAND | PHARMACIA & UPJOHN COMPANY (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999050416-A1 | TNF-RELATED DEATH LIGAND | PHARMACIA & UPJOHN COMPANY (US) | 1999-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11883426-B2 | Treatment for methamphetamine cardiovascular disease | CBS, MPST, TST | KLKB1 3114/4885HDAC11 1093/4885PLAU 3441/4885 |
| US-20240041917-A1 | TREATMENT FOR METHAMPHETAMINE CARDIOVASCULAR DISEASE | STS, MPST, TST | KLKB1 3708/4885HDAC11 789/4885PLAU 3105/4885 |
| US-20020048806-A1 | POULTRY VIRUS ISOLATES AND METHOD | C9, ALPI, ACIN1 | KLKB1 2861/4885HDAC11 2690/4885PLAU 3921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.